Missed Doses and Take-Home Dosing Patterns in Methadone and Buprenorphine Patients
BJPsych Open · 2026-06 · 12 (S1) · S224-S224
DOI: 10.1192/bjo.2026.11532 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 30.06.2026. Verfasst von Mohammad Ali. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Adherence to opioid substitution therapy is critical for treatment success, yet missed doses and unsupervised take-home doses can increase relapse or overdose risk. This service evaluation aimed to assess patterns of missed supervised doses and take-home medication use, identify factors associated with non-adherence, and evaluate potential service improvements.
Methods
A retrospective service evaluation was conducted in an addictions psychiatry outpatient clinic. Adults aged ≥18 years receiving methadone or buprenorphine for at least three months were included. Patients were excluded if they had transferred care during the evaluation period, had incomplete pharmacy records, or were unable to engage in routine clinic follow-up due to acute intoxication, severe withdrawal, cognitive impairment, or acute psychiatric instability. Data were extracted from clinic and pharmacy records, including supervised dose attendance, take-home dosing patterns, demographic information, concurrent substance use, and housing status. Descriptive statistics were used to summarise missedsupervised doses, take-home medication issues, and associated factors, with exploratory comparisons between patients with and without polysubstance use.
Results
A total of 120 patients on opioid substitution therapy (methadone n=75, buprenorphine n=45) were included in the service evaluation. Missed supervised doses were common, with 36 patients (30%) missing ≥2 doses in the preceding month and 18 patients (15%) missing ≥4 doses. Issues with take-home medication were documented in 22 patients (18%), including misplacement (n=12) and suspected diversion (n=10). Polysubstance use was prevalent, with 52 patients (43%) reporting concurrent use of cocaine, cannabis, or illicit benzodiazepines; missed supervised doses were more frequent among these patients (42% vs 21%, p
Zitieren
APA
Ali, M. (2026). Missed Doses and Take-Home Dosing Patterns in Methadone and Buprenorphine Patients. BJPsych Open, 12(S1), S224-S224. https://doi.org/10.1192/bjo.2026.11532
Vancouver
Ali M. Missed Doses and Take-Home Dosing Patterns in Methadone and Buprenorphine Patients. BJPsych Open. 2026;12(S1):S224-S224. doi:10.1192/bjo.2026.11532
BibTeX
@article{Ali2026,
author = {Ali, Mohammad},
title = {Missed Doses and Take-Home Dosing Patterns in Methadone and Buprenorphine Patients},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {S1},
pages = {S224--S224},
doi = {10.1192/bjo.2026.11532}
}
EUVIMED